By Colin Kellaher
Phathom Pharmaceuticals said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons.
Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director.
Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay.
The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 01, 2025 08:48 ET (12:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.